This is a knockout-validated antibody summary, based on the publications "The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue" (shown below) [1] and "Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis" (see figure 1a, western blot) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Rabbit monoclonal IgG
Company: Abcam
Antibody: FLCN
Catalog number: ab124885
Summary: Rabbit monoclonal IgG against a recombinant tagged protein fragment corresponding to human FLCN. Reacts with mouse, rat, and human by western blot. Unsuitable for flow cytometry ,immunocytochemistry, immunohistochemistry (paraffin) or immunoprecipitation.
Western blot
BAT and iWAT from WT and adipose tissue-specific deletion of FLCN. Tissue or cell samples were lysed by RIPA buffer containing phosphatase inhibitor (PhosSTOP, Roche) and proteinase inhibitor (Complete miniproteinase inhibitor cocktail, Roche).
5% skim milk for 1 h.
HRP-conjugated secondary antibodies.
Digital imager (GE Healthcare Life Sciences, ImageQuant LAS 4000).
- Wada S, Neinast M, Jang C, Ibrahim Y, Lee G, Babu A, et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 2016;30:2551-2564 pubmed
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.